Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (39)

2021

  1. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10

  2. HLA association with the susceptibility to anti-synthetase syndrome

    Joint Bone Spine, Vol. 88, Núm. 3

  3. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 395-403

  4. Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

2020

  1. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

  2. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

  3. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739

2018

  1. Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study

    Revista Espanola de Cardiologia, Vol. 71, Núm. 3, pp. 170-177

2016

  1. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  2. Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 34, pp. S84-S88

2015

  1. Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients

    Rheumatology International, Vol. 35, Núm. 12, pp. 2069-2078

2014

  1. Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 16, Núm. 4

  2. Lack of association between IL6 gene and Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82, pp. 141-142

  3. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis

    PLoS ONE, Vol. 9, Núm. 9

  4. Sex differences in patients with systemic lupus erythematosus from Northwest Spain

    Rheumatology International, Vol. 34, Núm. 1, pp. 11-24

2013

  1. Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis

    Clinical and Experimental Rheumatology

2012

  1. Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients

    DNA and Cell Biology, Vol. 31, Núm. 8, pp. 1412-1417

  2. Lack of association between flow-mediated endotheliumdependent vasodilatation and biomarkers of endothelial dysfunction in patients with severe rheumatoid arthritis

    Rheumatology International

  3. NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis

    Atherosclerosis, Vol. 224, Núm. 2, pp. 426-429